![Sherwin Sattarzadeh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sherwin Sattarzadeh
No más puestos en curso
Fortuna: 6 M $ al 31/07/2026
Perfil
Mr. Sherwin Sattarzadeh was previously employed as a Chief Executive & Operating Officer by Damora Therapeutics, Inc., a Chief Business Officer by Blueprint Medicines Corp., and a Director-Regulatory Affairs by Genzyme Corp.
He received his undergraduate degree from the University of British Columbia and an MBA from Boston University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 05/01/2026 | 190.376 ( 0,31 % ) | 6 M $ | 31/07/2026 |
Antiguos cargos conocidos de Sherwin Sattarzadeh.
| Empresas | Cargo | Fin |
|---|---|---|
| DAMORA THERAPEUTICS, INC. | Director Ejecutivo | 30/03/2026 |
| BLUEPRINT MEDICINES CORPORATION | Oficial de Recursos Humanos | - |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Consejero General | 01/07/2015 |
Formación de Sherwin Sattarzadeh.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
69
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
- Bolsa de valores
- Insiders
- Sherwin Sattarzadeh
